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2 
Micropulse	  (MIP)	  Treatment	  
•  Pioneer	  treatment	  by	  Thomas	  R.	  Friberg	  and	  associates	  in	  the	  late	  1990s.	  
•  Several	  published	  ar5cles	  for	  medical	  applica5on	  in	  DR,	  RVO	  and	  CSC.	  
•  Divides	   the	   laser	   emission	   into	   a	   “train”	   of	   short,	   repe::ve	   pulses	   that	  
persists	   for	   0.1	   to	   0.5	   seconds	   in	   a	   “on-­‐off	   :me”	   interval	   between	  
successive	  micropulses:	  duty-­‐cycle.	  
•  Treatment	  un:l	  100	  μm	  from	  fovea?	  
•  Possibility	  of	  undertreatment	  is	  a	  concern.	  
•  Not	  well	  estabilished.	  No	  standards	  or	  dose-­‐response	  clinical	  studies.	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3 
MIP	  Clinical	  Studies	  Available	  
•  Treatment	  in	  areas	  not	  suitable	  for	  conven:onal	  laser.	  
•  Con:nuous	  wave-­‐emission.	  	  
•  Power	  is	  5trated	  upward	  for	  a	  barely	  visible	  5ssue.	  
ü  577	  nm	  or	  810	  nm	  laser:	  	  
ü  Spot	  ~	  125	  μm	  	  	  
ü  Variable	  duty-­‐cycle:	  0.5-­‐10%	  
ü  Different	  power:	  50-­‐70%	  
4 
Supra 532® 
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5 
Material	  and	  Methods	  
•  Retrospec5ve,	  non-­‐compara5ve	  study.	  
•  Micropulse	  laser	  treatment	  data	  since	  June	  2012	  un5l	  March	  2013.	  
•  Diabe5c	  Macular	  Edema:	  
•  Not	  suitable	  for	  conven5onal	  laser	  treatment	  
•  Lack	  of	  response	  to	  intravitreal	  therapy	  (an5-­‐VEGF	  or	  cor5coid)	  
•  10%	  duty-­‐cycle	  5me,	  200ms	  
•  Spot	  diameter	  50μm	  	  




Total	  Sample	   140	  eyes.	  24	  eyes	  excluded.	  
Included	   116	  eyes	  89	  pa5ents	  
Distribu:on	  
58	  (50%)	  RE.	  	  
58	  (50%)	  LE.	  
	  
61	  male	  (52,6%)	  






number	   49	  
Average	  Power	   622±176	  mW	  
Follow-­‐up	  Time	  
Range	   4-­‐18	  months	  










Previous PPV Previous BVCZ IVI Previous TA IVI Previous LASER Treatment 
7	  (6%)	   78	  (67,2%)	   36	  (31%)	   99	  (85,3%)	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(99)	   N	   p	  value	  
No	   No	   No	   No	   5	   0,325	  
No	   No	   No	   Yes	   21	   0,160	  
No	   No	   Yes	   Yes	   3	   0,465	  
No	   Yes	   No	   No	   7	   0,034	  
No	   Yes	   No	   Yes	   34	   0,572	  
No	   Yes	   Yes	   No	   2	   0,195	  
No	   Yes	   Yes	   Yes	   24	   0,3111	  
Yes	   No	   Yes	   Yes	   2	   0,895	  
Yes	   Yes	   No	   Yes	   2	   0,690	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p	  =	  0,281	  
10 
Macular	  Thickness	  Varia5on	  
333±94,5	   329±110,4	   353±54,1	   351±72,2	  








FA	  and	  FAF	  findings	  
•  No	  visible	  LASER	  spots	  
•  No	  RPE	  changes	  


































•  Retrospec5ve	  and	  non-­‐compara5ve	  study	  
•  Non-­‐naïve	  pa5ents	  
•  Difficult	  metabolic	  control	  
•  Mul5ple	  variables	  involved	  
•  More	  follow-­‐up	  controlled	  5me	  
•  No	  published	  clinical	  trials	  with	  532	  nm	  
•  Correct	  parameters?	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